Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Rein Therapeutics Inc leads the sector with a market cap of $57.80 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Biotechnology Stocks by Market Capitalization (October 2026)
Top Biotechnology stocks by market capitalization as of October 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 751 |
Rein Therapeutics Inc
NASDAQ:RNTX |
$57.80 Million | $57.80 Million | USA | $0.67 | -7.79% | +11.22% | 10.67 Million |
| 752 |
Verrica Pharmaceuticals Inc
NASDAQ:VRCA |
$57.55 Million | $57.55 Million | USA | $3.35 | -2.05% | -12.53% | 1.20 Million |
| 753 |
XBiotech Inc
NASDAQ:XBIT |
$57.32 Million | $57.32 Million | USA | $1.88 | -3.09% | -4.57% | 1.95 Million |
| 754 |
Bonus Biogroup
TA:BONS |
$56.36 Million | ILA21.02 Billion | Israel | ILA18.00 | +2.86% | -0.55% | 15.91 Million |
| 755 |
LTR Pharma Ltd
AU:LTP |
$55.31 Million | AU$78.16 Million | Australia | AU$0.43 | -1.15% | -10.42% | 3.78 Million |
| 756 |
ONDINE BIOMEDICAL INC.CDI
F:VF5 |
$55.27 Million | €47.28 Million | Germany | €0.09 | -35.46% | -8.54% | 0.00 |
| 757 |
Island Pharmaceuticals Ltd
AU:ILA |
$55.21 Million | AU$78.03 Million | Australia | AU$0.29 | -10.77% | -9.38% | 5.94 Million |
| 758 |
Synthaverse S.A.
WAR:SVE |
$55.05 Million | zł200.03 Million | Poland | zł2.64 | -0.38% | -2.94% | 947.37K |
| 759 |
Helix BioPharma Corp.
TO:HBP |
$54.70 Million | CA$75.61 Million | Canada | CA$0.99 | +0.00% | +1.02% | 275.15K |
| 760 |
Eloxx Pharmaceuticals, Inc.
NASDAQ:ELOX |
$54.29 Million | $54.29 Million | USA | $13.45 | +1.89% | +2.52% | 557.20K |
| 761 |
Mink Therapeutics Inc
NASDAQ:INKT |
$53.73 Million | $53.73 Million | USA | $10.53 | -3.17% | +4.67% | 441.14K |
| 762 |
Fluoguide AS
ST:FLUO |
$53.66 Million | Skr498.65 Million | Sweden | Skr30.50 | -3.17% | -1.29% | 160.31K |
| 763 |
Kronos Bio Inc
NASDAQ:KRON |
$53.65 Million | $53.65 Million | USA | $0.88 | +0.00% | +0.00% | 54.09K |
| 764 |
Pliant Therapeutics Inc
NASDAQ:PLRX |
$53.18 Million | $53.18 Million | USA | $0.86 | -0.13% | -0.74% | 8.86 Million |
| 765 |
Yarrow Bioscience Inc
NASDAQ:YARW |
$53.13 Million | $53.13 Million | USA | $19.90 | -0.50% | +1.53% | 3.28 Million |
| 766 |
Xilio Development Inc
NASDAQ:XLO |
$52.84 Million | $52.84 Million | USA | $8.03 | +3.35% | +0.00% | 326.16K |
| 767 |
ImmunoPrecise Antibodies Ltd.
NASDAQ:HYFT |
$52.76 Million | $52.76 Million | USA | $1.13 | -5.83% | -5.83% | 6.91 Million |
| 768 |
Heron Therapeuti
NASDAQ:HRTX |
$52.56 Million | $52.56 Million | USA | $0.28 | -5.67% | -6.25% | 53.96 Million |
| 769 |
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV |
$52.38 Million | $52.38 Million | USA | $1.66 | -5.68% | -5.68% | 4.99 Million |
| 770 |
Ultimovacs ASA
OL:ULTI |
$52.14 Million | Nkr495.45 Million | Norway | Nkr14.40 | +0.00% | +0.00% | 8.70K |
| 771 |
OSE Pharma SA
PA:OSE |
$51.16 Million | €43.76 Million | France | €1.95 | -7.31% | -4.41% | 3.88 Million |
| 772 |
Klotho Neurosciences, Inc.
NASDAQ:KLTO |
$50.59 Million | $50.59 Million | USA | $0.47 | -10.72% | +13.43% | 161.05 Million |
| 773 |
Connect Biopharma Holdings Ltd
NASDAQ:CNTB |
$50.52 Million | $50.52 Million | USA | $0.80 | -3.97% | +5.26% | 202.44 Million |
| 774 |
FLUOGUIDE A/S DK -1
F:96X |
$50.27 Million | €43.00 Million | Germany | €2.63 | +1.15% | +0.00% | 0.00 |
| 775 |
Hyperion DeFi, Inc.
NASDAQ:HYPD |
$50.04 Million | $50.04 Million | USA | $3.22 | -8.13% | +10.27% | 7.84 Million |
| 776 |
EyeGene Inc
KQ:185490 |
$49.94 Million | ₩73.70 Billion | Korea | ₩1705.00 | -2.57% | -8.58% | 1.54 Million |
| 777 |
iBio, Inc. Common Stock
NASDAQ:IBIO |
$49.43 Million | $49.43 Million | USA | $0.77 | -5.52% | -1.95% | 18.70 Million |
| 778 |
Mereo BioPharma Group PLC ADR
NASDAQ:MREO |
$48.79 Million | $48.79 Million | USA | $0.31 | -4.60% | -9.50% | 37.78 Million |
| 779 |
Bluebird bio Inc
NASDAQ:BLUE |
$48.67 Million | $48.67 Million | USA | $4.97 | +0.00% | +0.00% | 1.25 Million |
| 780 |
Kalaris Therapeutics, Inc.
NASDAQ:KLRS |
$48.30 Million | $48.30 Million | USA | $2.03 | -4.69% | +2.01% | 1.89 Million |
| 781 |
Gain Therapeutics Inc
NASDAQ:GANX |
$48.20 Million | $48.20 Million | USA | $1.13 | -5.04% | -12.40% | 15.29 Million |
| 782 |
Annovis Bio Inc
NYSE:ANVS |
$48.07 Million | $48.07 Million | USA | $1.13 | +10.78% | +13.95% | 17.57 Million |
| 783 |
Theranexus SA
PA:ALTHX |
$48.02 Million | €41.07 Million | France | €3.31 | -4.89% | +3.44% | 1.26 Million |
| 784 |
Werewolf Therapeutics Inc
NASDAQ:HOWL |
$46.90 Million | $46.90 Million | USA | $0.99 | -10.35% | -2.37% | 10.78 Million |
| 785 |
ImageneBio, Inc.
NASDAQ:IMA |
$46.63 Million | $46.63 Million | USA | $4.10 | +1.23% | +1.36% | 309.86K |
| 786 |
IGM Biosciences Inc
NASDAQ:IGMS |
$46.47 Million | $46.47 Million | USA | $1.27 | +0.00% | +0.00% | 1.62 Million |
| 787 |
LeonaBio, Inc.
NASDAQ:LONA |
$46.40 Million | $46.40 Million | USA | $4.94 | +0.61% | -0.60% | 9.29 Million |
| 788 |
Biomea Fusion Inc
NASDAQ:BMEA |
$46.24 Million | $46.24 Million | USA | $0.64 | +2.68% | +9.32% | 59.26 Million |
| 789 |
Instil Bio Inc.
NASDAQ:TIL |
$46.12 Million | $46.12 Million | USA | $6.80 | -0.37% | +19.30% | 1.19 Million |
| 790 |
GenMont Biotech Inc
TW:3164 |
$45.80 Million | NT$1.45 Billion | Taiwan | NT$16.90 | +0.00% | +0.00% | 1.25 Million |
| 791 |
LAVA Therapeutics NV
NASDAQ:LVTX |
$45.77 Million | $45.77 Million | USA | $1.74 | +0.00% | -3.87% | 2.28 Million |
| 792 |
Impact BioMedical, Inc.
NYSE MKT:IBO |
$45.54 Million | $45.54 Million | USA | $0.44 | +0.07% | +4.89% | 409.59K |
| 793 |
Caribou Biosciences Inc
NASDAQ:CRBU |
$45.37 Million | $45.37 Million | USA | $0.42 | -4.90% | -24.43% | 121.38 Million |
| 794 |
Arovella Therapeutics Ltd
AU:ALA |
$45.33 Million | AU$64.07 Million | Australia | AU$0.05 | +3.92% | +8.16% | 18.23 Million |
| 795 |
Immutep Limited
F:YP1A |
$45.10 Million | €38.57 Million | Germany | €2.76 | -2.13% | -30.09% | 12.00 |
| 796 |
Naturalendo Tech Co Ltd
KQ:168330 |
$44.72 Million | ₩65.99 Billion | Korea | ₩2090.00 | +1.21% | +2.45% | 231.43K |
| 797 |
Elicio Therapeutics Inc.
NASDAQ:ELTX |
$44.15 Million | $44.15 Million | USA | $1.68 | -4.00% | -13.40% | 6.78 Million |
| 798 |
OS Therapies Incorporated
NYSE MKT:OSTX |
$42.96 Million | $42.96 Million | USA | $1.73 | -4.95% | -7.98% | 19.37 Million |
| 799 |
Cantargia AB
ST:CANTA |
$42.86 Million | Skr398.28 Million | Sweden | Skr1.60 | -4.19% | +17.36% | 52.41 Million |
| 800 |
SMS Lifesciences India Limited
NSE:SMSLIFE |
$42.13 Million | Rs3.90 Billion | India | Rs1288.50 | -6.64% | -3.37% | 56.32K |
| 801 |
CTCBIO Inc
KQ:060590 |
$41.88 Million | ₩61.80 Billion | Korea | ₩2585.00 | -1.90% | -4.44% | 991.70K |
| 802 |
Inovio Pharmaceuticals Inc
NASDAQ:INO |
$41.39 Million | $41.39 Million | USA | $0.60 | -21.95% | -28.19% | 110.42 Million |
| 803 |
Lite Strategy, Inc.
NASDAQ:LITS |
$41.18 Million | $41.18 Million | USA | $1.12 | -4.27% | -5.88% | 9.55 Million |
| 804 |
Sprint Bioscience AB
ST:SPRINT |
$40.88 Million | Skr379.86 Million | Sweden | Skr3.60 | +2.86% | +7.46% | 5.63 Million |
| 805 |
Arch Biopartners Inc
V:ARCH |
$40.79 Million | CA$56.38 Million | Canada | CA$0.83 | +2.47% | -4.60% | 673.39K |
| 806 |
INmune Bio Inc
NASDAQ:INMB |
$40.24 Million | $40.24 Million | USA | $1.45 | -9.38% | -5.84% | 6.42 Million |
| 807 |
Corline Biomedical AB
ST:CLBIO |
$39.94 Million | Skr371.09 Million | Sweden | Skr14.20 | -0.70% | +3.65% | 189.85K |
| 808 |
Prescient Therapeutics Ltd
AU:PTX |
$39.43 Million | AU$55.73 Million | Australia | AU$0.05 | -3.64% | -5.36% | 17.31 Million |
| 809 |
Alterity Therapeutics Ltd
NASDAQ:ATHE |
$39.33 Million | $39.33 Million | USA | $2.16 | -3.29% | +0.47% | 691.27K |
| 810 |
PanGen Biotech Inc
KQ:222110 |
$39.19 Million | ₩57.82 Billion | Korea | ₩4285.00 | -7.05% | -10.45% | 141.63K |
| 811 |
Raphas Co. Ltd
KQ:214260 |
$39.09 Million | ₩57.68 Billion | Korea | ₩6860.00 | +0.00% | -2.56% | 185.50K |
| 812 |
LAVA THERAP. B.V. EO-12
F:4PKB |
$38.54 Million | €32.96 Million | Germany | €1.44 | -6.49% | +5.88% | 14.00K |
| 813 |
BioInvent International AB
ST:BINV |
$38.45 Million | Skr357.32 Million | Sweden | Skr5.43 | -4.90% | -73.51% | 9.16 Million |
| 814 |
Tevogen Bio Holdings Inc.
NASDAQ:TVGN |
$38.42 Million | $38.42 Million | USA | $5.90 | -2.48% | -13.36% | 203.04K |
| 815 |
OKYO PHARMA LTD SP.ADR/65
F:OK10 |
$38.38 Million | €32.83 Million | Germany | €1.36 | +0.00% | +0.00% | 0.00 |
| 816 |
DNA Biomed Solns
TA:DNA |
$38.30 Million | ILA14.29 Billion | Israel | ILA116.00 | +1.93% | +0.78% | 7.62 Million |
| 817 |
Avecho Biotechnology Ltd
AU:AVE |
$38.27 Million | AU$54.09 Million | Australia | AU$0.01 | +7.69% | -6.67% | 121.45 Million |
| 818 |
Abnova Taiwan Corp
TW:4133 |
$38.16 Million | NT$1.21 Billion | Taiwan | NT$20.00 | -2.44% | -4.31% | 5.44 Million |
| 819 |
Dogwood Therapeutics, Inc.
NASDAQ:DWTX |
$38.05 Million | $38.05 Million | USA | $1.28 | +4.07% | +14.29% | 1.70 Million |
| 820 |
Cellid Co. Ltd
KQ:299660 |
$37.63 Million | ₩55.52 Billion | Korea | ₩1882.00 | +1.13% | -13.47% | 20.63 Million |
| 821 |
FibroGen Inc
NASDAQ:FGEN |
$37.30 Million | $37.30 Million | USA | $9.22 | -5.05% | +5.98% | 925.11K |
| 822 |
Actinium Pharmaceuticals Inc
NYSE MKT:ATNM |
$37.02 Million | $37.02 Million | USA | $1.18 | +0.00% | -7.81% | 4.49 Million |
| 823 |
Herantis Pharma Oyj
HE:HRTIS |
$36.56 Million | €31.27 Million | Finland | €1.18 | -1.67% | -3.75% | 663.58K |
| 824 |
Relief Therapeutics Holding AG
SW:RLF |
$36.33 Million | CHF28.73 Million | Switzerland | CHF2.89 | +0.87% | +3.41% | 379.74K |
| 825 |
Mendus AB (publ)
ST:IMMU |
$36.27 Million | Skr337.06 Million | Sweden | Skr5.50 | +6.38% | +3.77% | 512.27K |
| 826 |
Isofol Medical AB
ST:ISOFOL |
$36.24 Million | Skr336.77 Million | Sweden | Skr1.20 | +0.84% | +25.45% | 29.29 Million |
| 827 |
Generation Bio Co
NASDAQ:GBIO |
$35.98 Million | $35.98 Million | USA | $5.34 | -6.97% | -4.81% | 2.86 Million |
| 828 |
Entropy Neurodynamics Limited
AU:ENP |
$35.83 Million | AU$50.64 Million | Australia | AU$0.03 | +3.33% | -3.13% | 32.40 Million |
| 829 |
Mural Oncology plc
NASDAQ:MURA |
$35.38 Million | $35.38 Million | USA | $2.04 | +0.00% | +0.49% | 4.99 Million |
| 830 |
Atara Biotherapeutics Inc
NASDAQ:ATRA |
$35.19 Million | $35.19 Million | USA | $8.01 | -6.10% | -15.06% | 780.54K |
| 831 |
Veru Inc
NASDAQ:VERU |
$35.15 Million | $35.15 Million | USA | $2.19 | -1.79% | -4.37% | 4.74 Million |
| 832 |
Mabion S.A.
WAR:MAB |
$35.14 Million | zł127.68 Million | Poland | zł7.90 | -0.25% | -5.05% | 641.90K |
| 833 |
eXoZymes, Inc.
NASDAQ:EXOZ |
$35.02 Million | $35.02 Million | USA | $4.13 | +0.49% | +5.90% | 277.11K |
| 834 |
Edesa Biotech Inc
NASDAQ:EDSA |
$34.72 Million | $34.72 Million | USA | $2.57 | -4.81% | -6.88% | 1.08 Million |
| 835 |
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK |
$34.41 Million | $34.41 Million | USA | $0.47 | -5.15% | -16.93% | 104.82 Million |
| 836 |
Aldeyra The
NASDAQ:ALDX |
$33.80 Million | $33.80 Million | USA | $0.56 | -14.99% | -13.17% | 44.70 Million |
| 837 |
GeneOne Life Science Inc
KO:011000 |
$32.81 Million | ₩48.42 Billion | Korea | ₩2670.00 | +0.00% | +362.74% | 75.58 Million |
| 838 |
Molecure S.A.
WAR:MOC |
$32.77 Million | zł119.09 Million | Poland | zł5.78 | -1.20% | -3.34% | 955.44K |
| 839 |
Lipum AB
ST:LIPUM |
$32.76 Million | Skr304.40 Million | Sweden | Skr14.35 | +0.70% | +1.77% | 1.28 Million |
| 840 |
Oncoinvent ASA
OL:ONCIN |
$32.52 Million | Nkr309.01 Million | Norway | Nkr69.00 | -1.15% | +2.99% | 597.23K |
| 841 |
NovaBay Pharmaceuticals Inc
NYSE MKT:NBY |
$32.22 Million | $32.22 Million | USA | $1.21 | +4.31% | -13.57% | 3.36 Million |
| 842 |
Adicet Bio Inc
NASDAQ:ACET |
$32.02 Million | $32.02 Million | USA | $3.42 | -4.47% | -20.09% | 5.33 Million |
| 843 |
Mereo BioPharma Group plc
F:MAH0 |
$31.92 Million | €27.31 Million | Germany | €0.26 | +9.24% | +4.84% | 8.60K |
| 844 |
NUREXONE BIOLOGIC INC.
F:J90 |
$31.64 Million | €27.06 Million | Germany | €0.29 | -2.00% | -9.26% | 22.52K |
| 845 |
Xbrane Biopharma AB
ST:XBRANE |
$31.38 Million | Skr291.57 Million | Sweden | Skr14.15 | +8.85% | +11.86% | 4.44 Million |
| 846 |
Level Biotechnology
TWO:3118 |
$31.29 Million | NT$993.06 Million | Taiwan | NT$30.60 | -0.16% | -0.65% | 358.74K |
| 847 |
CORESTEM Inc
KQ:166480 |
$31.15 Million | ₩45.96 Billion | Korea | ₩1636.00 | -1.45% | -2.15% | 3.26 Million |
| 848 |
Quince Therapeutics, Inc.
NASDAQ:QNCX |
$30.87 Million | $30.87 Million | USA | $32.95 | +4.21% | +0.37% | 1.80 Million |
| 849 |
Amplia Therapeutics Ltd
AU:ATX |
$30.51 Million | AU$43.12 Million | Australia | AU$0.08 | -5.62% | +7.69% | 29.80 Million |
| 850 |
SoftOx Solutions AS
OL:SOFTX |
$30.23 Million | Nkr287.28 Million | Norway | Nkr0.11 | -2.53% | -5.10% | 708.20 Million |
| 851 |
Jiangsu Wuzhong Industrial Co Ltd
SHG:600200 |
$30.17 Million | CN¥206.16 Million | China | CN¥0.29 | +0.00% | -9.38% | 993.60 Million |
| 852 |
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM |
$30.09 Million | $30.09 Million | USA | $20.69 | -0.53% | -5.95% | 303.14K |
| 853 |
Filana Therapeutics, Inc.
NASDAQ:FLNA |
$30.05 Million | $30.05 Million | USA | $0.62 | -5.47% | -4.91% | 14.18 Million |
| 854 |
Grace Therapeutics, Inc.
NASDAQ:GRCE |
$30.02 Million | $30.02 Million | USA | $1.94 | +0.00% | +1.31% | 2.83 Million |
| 855 |
Genoway
PA:ALGEN |
$29.86 Million | €25.54 Million | France | €2.07 | +0.00% | -5.91% | 195.29K |
| 856 |
Allakos Inc
NASDAQ:ALLK |
$29.74 Million | $29.74 Million | USA | $0.33 | +0.00% | +0.00% | 725.84K |
| 857 |
Microbix Biosystems Inc.
TO:MBX |
$29.72 Million | CA$41.09 Million | Canada | CA$0.30 | +3.45% | -6.25% | 579.94K |
| 858 |
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD |
$29.61 Million | $29.61 Million | USA | $1.36 | -5.56% | -65.57% | 31.04 Million |
| 859 |
Lyka Labs Limited
NSE:LYKALABS |
$29.57 Million | Rs2.73 Billion | India | Rs76.60 | +0.46% | -7.31% | 523.87K |
| 860 |
Metagenomi, Inc. Common Stock
NASDAQ:MGX |
$29.48 Million | $29.48 Million | USA | $0.78 | -6.01% | -4.40% | 3.84 Million |
| 861 |
Karolinska Development AB ser. B
ST:KDEV |
$29.36 Million | Skr272.85 Million | Sweden | Skr0.29 | +0.00% | +0.00% | 14.10 Million |
| 862 |
GeneReach Biotechnology
TWO:4171 |
$29.29 Million | NT$929.62 Million | Taiwan | NT$16.35 | -1.80% | -4.39% | 7.16 Million |
| 863 |
Barinthus Biotherapeutics plc
NASDAQ:BRNS |
$28.99 Million | $28.99 Million | USA | $0.74 | +0.00% | +2.86% | 1.58 Million |
| 864 |
NextCure Inc
NASDAQ:NXTC |
$28.88 Million | $28.88 Million | USA | $6.31 | -3.30% | +33.69% | 1.61 Million |
| 865 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
$28.84 Million | $28.84 Million | USA | $0.35 | -8.32% | -18.62% | 368.36 Million |
| 866 |
MINDMAZE THERAPEUTICS HOLDING SA
SW:MMTX |
$28.56 Million | CHF22.59 Million | Switzerland | CHF0.15 | -8.16% | -2.37% | 18.90 Million |
| 867 |
Intervacc AB
ST:IVACC |
$28.31 Million | Skr263.11 Million | Sweden | Skr0.77 | -1.03% | -7.10% | 7.95 Million |
| 868 |
Vivoryon Therapeutics NV
AS:VVY |
$27.77 Million | €23.75 Million | Netherlands | €0.80 | -2.67% | -9.48% | 1.31 Million |
| 869 |
Estrella Immunopharma Inc.
NASDAQ:ESLA |
$27.75 Million | $27.75 Million | USA | $0.64 | -12.27% | -12.04% | 107.49 Million |
| 870 |
Sangamo Therapeutics Inc
NASDAQ:SGMO |
$27.50 Million | $27.50 Million | USA | $0.07 | +0.00% | +0.00% | 83.11 Million |
| 871 |
Medicenna Therapeutics Corp
TO:MDNA |
$27.46 Million | CA$37.96 Million | Canada | CA$0.46 | -5.21% | +8.33% | 1.43 Million |
| 872 |
PolTREG S.A.
WAR:PTG |
$27.34 Million | zł99.33 Million | Poland | zł21.30 | +4.41% | +3.40% | 83.96K |
| 873 |
India Globalization Capital Inc
NYSE MKT:IGC |
$26.91 Million | $26.91 Million | USA | $0.29 | +0.38% | -3.01% | 21.20 Million |
| 874 |
ABVC Biopharma Inc
NASDAQ:ABVC |
$26.65 Million | $26.65 Million | USA | $1.00 | -3.85% | -4.52% | 1.46 Million |
| 875 |
Athira Pharma Inc
NASDAQ:ATHA |
$26.62 Million | $26.62 Million | USA | $7.66 | +10.85% | +25.78% | 1.34 Million |
| 876 |
Cue Biopharma
NASDAQ:CUE |
$26.56 Million | $26.56 Million | USA | $20.87 | -2.70% | +10.48% | 4.16 Million |
| 877 |
Oxford Nanopore Technologies Ltd
LSE:ONT |
$26.47 Million | GBX217.59 Billion | UK | GBX222.60 | -4.63% | +5.30% | 49.53 Million |
| 878 |
BeyondSpring Inc
NASDAQ:BYSI |
$26.47 Million | $26.47 Million | USA | $0.64 | +24.60% | +44.64% | 4.01 Million |
| 879 |
Briacell Therapeutics Corp
NASDAQ:BCTX |
$26.45 Million | $26.45 Million | USA | $3.04 | -8.16% | -10.85% | 1.61 Million |
| 880 |
Evaxion Biotech AS
NASDAQ:EVAX |
$26.43 Million | $26.43 Million | USA | $2.93 | -4.87% | -21.02% | 2.69 Million |
| 881 |
Plus Therapeutics Inc
NASDAQ:PSTV |
$26.42 Million | $26.42 Million | USA | $3.84 | +1.80% | +5.15% | 2.61 Million |
| 882 |
Renovaro Biosciences Inc
NASDAQ:RENB |
$26.19 Million | $26.19 Million | USA | $1.13 | +0.00% | +0.00% | 461.97K |
| 883 |
Aligos Therapeutics Inc
NASDAQ:ALGS |
$25.86 Million | $25.86 Million | USA | $4.80 | -4.57% | -0.41% | 770.89K |
| 884 |
LakeShore Biopharma Co., Ltd
NASDAQ:LSB |
$25.84 Million | $25.84 Million | USA | $0.63 | +0.00% | -26.63% | 69.34K |
| 885 |
Avecho Biotechnology Limited
F:OEZ |
$25.76 Million | €22.04 Million | Germany | €0.01 | +0.00% | +16.67% | 0.00 |
| 886 |
Boundless Bio, Inc. Common Stock
NASDAQ:BOLD |
$25.63 Million | $25.63 Million | USA | $2.47 | -0.40% | +1.23% | 3.89 Million |
| 887 |
MedMira Inc
V:MIR |
$25.38 Million | CA$35.09 Million | Canada | CA$0.05 | +0.00% | -16.67% | 1.73 Million |
| 888 |
iBio, Inc. Common Stock
NYSE MKT:IBIO |
$24.96 Million | $24.96 Million | USA | $1.20 | -6.25% | +0.00% | 31.77 Million |
| 889 |
CervoMed Inc.
NASDAQ:CRVO |
$24.19 Million | $24.19 Million | USA | $1.60 | -8.57% | -28.57% | 8.24 Million |
| 890 |
Kainos Medicine Inc
KQ:284620 |
$24.10 Million | ₩35.56 Billion | Korea | ₩1087.00 | +0.00% | +0.00% | 883.91K |
| 891 |
Immutep Ltd
AU:IMM |
$23.95 Million | AU$33.85 Million | Australia | AU$0.02 | +0.00% | +4.55% | 178.57 Million |
| 892 |
Eutilex.Co.Ltd
KQ:263050 |
$23.94 Million | ₩35.32 Billion | Korea | ₩959.00 | +29.95% | +29.59% | 23.44 Million |
| 893 |
Longeveron LLC
NASDAQ:LGVN |
$23.60 Million | $23.60 Million | USA | $1.67 | -4.57% | +5.03% | 1.72 Million |
| 894 |
WOOJUNG BIO Inc
KQ:215380 |
$23.10 Million | ₩34.09 Billion | Korea | ₩2045.00 | -3.76% | -1.45% | 1.97 Million |
| 895 |
Celularity Inc
NASDAQ:CELU |
$23.07 Million | $23.07 Million | USA | $0.80 | -5.79% | -23.80% | 4.02 Million |
| 896 |
CESSATECH A/S DK -20
F:8GN |
$22.85 Million | €19.54 Million | Germany | €1.08 | -6.49% | -2.70% | 17.93K |
| 897 |
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG |
$22.48 Million | $22.48 Million | USA | $0.93 | +0.20% | -8.82% | 3.05 Million |
| 898 |
Maat Pharma SA
PA:MAAT |
$22.32 Million | €19.09 Million | France | €1.02 | -4.86% | -4.14% | 2.09 Million |
| 899 |
Kadimastem Ltd
TA:KDST |
$22.18 Million | ILA8.27 Billion | Israel | ILA2794.00 | +0.00% | +0.00% | 0.00 |
| 900 |
RTA Laboratuvarlari Biyolojik
IS:RTALB |
$22.17 Million | TL990.00 Million | Turkey | TL1.98 | +2.06% | -0.50% | 887.57 Million |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries